天弘恒生沪深港创新药精选50ETF发起联接A(014564)份额变动
| 截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
| 2024-12-30 |
31,028,329.02 |
29,030,432.06 |
6,377,971.10 |
8,375,868.06 |
| 2024-09-29 |
30,537,147.88 |
31,028,329.02 |
3,683,430.43 |
3,192,249.29 |
| 2024-06-29 |
29,234,282.20 |
30,537,147.88 |
4,404,604.82 |
3,101,739.14 |
| 2024-03-30 |
30,518,640.88 |
29,234,282.20 |
5,642,377.02 |
6,926,735.70 |
| 2023-12-30 |
21,941,017.41 |
30,518,640.88 |
16,942,105.43 |
8,364,481.96 |
| 2023-09-29 |
17,034,502.78 |
21,941,017.41 |
7,239,719.57 |
2,333,204.94 |
| 2023-06-29 |
12,290,520.40 |
17,034,502.78 |
9,448,551.21 |
4,704,568.83 |
| 2023-03-30 |
10,605,952.00 |
12,290,520.40 |
5,028,984.78 |
3,344,416.38 |
| 2022-12-30 |
9,232,301.72 |
10,605,952.00 |
4,397,946.36 |
3,024,296.08 |
| 2022-09-29 |
6,328,567.86 |
9,232,301.72 |
5,499,166.60 |
2,595,432.74 |
微信公众号
证券之星APP
基本资料
